corona virus 2019-ncov flu outbreak, covid-19 3d banner illustration, microscopic view of floating influenza virus cells

Boosting research into post-infectious diseases: Helmholtz Munich coordinates new NAKO data resource

Awards & Grants Environmental Health EPI

Helmholtz Munich is coordinating NAKO-PAIS, a project to expand the database of the German National Cohort (NAKO) for research into post-infectious diseases such as Long COVID and ME/CFS. The Federal Ministry of Research, Technology and Space (BMFTR) is funding the project with 27.8 million euros. Over the next two years, the NAKO health data will be supplemented with genetic, immunological and other molecular analyses.

See more from Helmholtz Munich on Google. Activate

Helmholtz Munich plays a leading role in NAKO-PAIS, a new project that aims to create a comprehensive database for research into post-infectious diseases over the next two years. 

Prof. Annette Peters, Director of the Institute of Epidemiology at Helmholtz Munich and Chair of the Board of Directors of NAKO e.V., is coordinating the project management and the genetic analyses. Dr. Harald Grallert, also at Helmholtz Munich, is coordinating the molecular data. 

Within the project, the health data from the German National Cohort (NAKO) will be supplemented with genetic, immunological and other molecular analyses. This expands the existing wealth of NAKO data so that it can be used for countless research projects on post-infectious diseases.

NAKO e.V. is receiving 27.8 million euros from the Federal Ministry of Research, Technology and Space (BMFTR) for NAKO-PAIS. The project forms part of the National Decade against Post-Infectious Diseases. This ten-year BMFTR initiative has a total budget of 500 million euros. It aims to investigate causes and disease mechanisms and to develop new approaches to diagnosis and treatment, so that care for those affected improves in the long term.

Gaining a better understanding of symptoms following infections

Post-acute infection syndromes (PAIS) encompass long-lasting health problems that may occur following an infection. These include Long COVID as well as other post-infectious conditions, such as myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS). The main symptom of ME/CFS is post-exertional malaise (PEM), a marked worsening of existing symptoms following physical or mental exertion.

The causes and biological mechanisms underlying these conditions are still poorly understood. NAKO-PAIS will establish a comprehensive, long-term data resource that enables researchers to investigate potential risk factors, disease mechanisms and the biological characteristics of resilience and recovery.

Long-term data and biological samples from NAKO

The project uses data and biological samples from NAKO, Germany’s largest population-based longitudinal study. More than 205,000 people across the country are taking part. The research began in 2014. Further surveys took place during and after the pandemic and are continuing as part of the ongoing 10-year follow-up. This allows the researchers to include health data from before, during and after the COVID-19 pandemic.

“The particular strength of the funded project lies in combining the extensive data from ten years of the NAKO study with PAIS-specific questionnaires, genetic data, antibody analyses and further molecular analyses. This unique combination of data enables researchers to identify risk factors for long-term symptoms caused by infections, to better understand different disease courses and to investigate the biological mechanisms underlying post-acute infection syndromes in a targeted manner”, says Peters.

Extensive molecular analyses

NAKO-PAIS also complements clinical trials by providing a population-based perspective. It includes people without a diagnosis, people with a mild disease course, and control groups without long-term symptoms. This lets researchers compare potential risk and protective factors as well as different disease trajectories.

A key part of the molecular analysis is genome sequencing, supplemented by serolomics techniques. These techniques analyse antibody patterns against various pathogens and can therefore show evidence of previous infections. Researchers can then better investigate which symptoms are associated with specific pathogens and which biological characteristics play a role in different post-infectious conditions.

Strong network of partners

In addition to Helmholtz Munich, several other institutions are involved. Prof. Berit Lange at the Helmholtz Centre for Infection Research (HZI) is coordinating the serolomics procedures. The German Cancer Research Centre (DKFZ) contributes in the field of serolomics (Dr Tim Waterboer) and in data storage and provision (Prof. Oliver Stegle). The University of Münster contributes in the field of infectious disease epidemiology (Prof. André Karch).

No new participants possible

The molecular analyses in NAKO-PAIS are based on existing NAKO participants. They were randomly selected at the start of the study in 2014 through their regional registration office and invited to the examinations by their designated study centre. It is therefore not possible for new participants to join the study at this stage.

Annette Peters
Prof. Dr. Annette Peters

Director of the Institute of Epidemiology

View profile
Harald Grallert, AME
Dr. Harald Grallert

Head of Research Group 'Diabetes and Related Traits', Scientist

View profile

Related news

corona virus 2019-ncov flu outbreak, covid-19 3d banner illustration, microscopic view of floating influenza virus cells

Environmental Health, EPI,

Nako Becomes a Key Pillar of the National Decade on "Post-Infectious Diseases"

NAKO, the German National Cohort, will play a key role in the National Decade on "Post-Infectious Diseases", initiated by the German Federal Ministry of Research, Technology, and Space (BMFTR). Building on its years of foundational work, NAKO…

Read more

Bioprobenbehälter

Environmental Health, EPI,

NAKO Launches the Pilot Phase of Its Trusted Research Environment

At the start of the pilot for a Trusted Research Environment (TRE), the German National Cohort (NAKO e.V.) is inviting research companies to submit applications for the use of NAKO data for scientific purposes. For the first time, it will now be…

Read more